advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (123)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Chen HY
Optometry and Vision Science 2015; 92: e227-e232
60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Hovakimyan M
Translational vision science & technology 2015; 4: 14
61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Aihara M
Journal of Glaucoma 2016; 25: e610-e614
61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Zhu W
Journal of Ophthalmology 2015; 2015: 165475
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Halkiadakis I
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Saini M
Eye 2015; 29: 808-814
61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Pérez-Roca F
PLoS ONE 2015; 10: e0129419
61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Peace JH
American Journal of Ophthalmology 2015; 160: 266-274.e1
61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Kim JH
Korean Journal of Ophthalmology 2015; 29: 270-279
60980 Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma
Ibrahim MM
Translational vision science & technology 2015; 4: 12
61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Schoenberg ED
Translational vision science & technology 2015; 4: 4
61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Ng XW
Drug delivery and translational research 2015; 5: 469-479
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Prabhasawat P
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Rodriguez-Aller M
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214
61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Voss K
Journal of Controlled Release 2015; 214: 1-11
61068 The Degradation of Mitomycin C Under Various Storage Methods
Kinast RM
Journal of Glaucoma 2016; 25: 477-481
61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Hsu KH
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321
61590 The Impact of Glaucoma Medications on Corneal Wound Healing
Pinheiro R
Journal of Glaucoma 2016; 25: 122-127
61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Cvenkel B
Clinical Ophthalmology 2015; 9: 625-631
61672 Volumetric and cost evaluation study of glaucoma medical therapy
Banga HK
International journal of applied & basic medical research 2015; 5: 96-99
61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Lin CL
Optometry and Vision Science 2015; 92: e227-e232
61590 The Impact of Glaucoma Medications on Corneal Wound Healing
Panfil C
Journal of Glaucoma 2016; 25: 122-127
61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Rodrigo-Morales E
PLoS ONE 2015; 10: e0129419
61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Guinchard S
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214
61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Falke K
Journal of Controlled Release 2015; 214: 1-11
